Fluorescence-guided surgery with live molecular navigation - a new cutting edge

被引:470
作者
Nguyen, Quyen T. [1 ]
Tsien, Roger Y. [2 ]
机构
[1] Univ Calif San Diego, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pharmacol, Howard Hughes Med Inst, La Jolla, CA 92093 USA
关键词
CELL-PENETRATING PEPTIDES; POSITIVE SURGICAL MARGINS; FOLATE RECEPTOR-ALPHA; IN-VIVO FLUORESCENCE; PROTEASE ACTIVITY; RADICAL PROSTATECTOMY; 5-AMINOLEVULINIC ACID; INDOCYANINE GREEN; CONTRAST AGENTS; OVARIAN-CANCER;
D O I
10.1038/nrc3566
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A glowing new era in cancer surgery may be dawning. Using fluorescently labelled markers, surgical molecular navigation means that tumours and nerves can be displayed in real time intra-operatively in contrasting pseudocolours, which allows more complete tumour resection while preserving important structures. These advances can potentially cause a paradigm shift in cancer surgery, improving patient outcome and decreasing overall health-care costs.
引用
收藏
页码:653 / 662
页数:10
相关论文
共 74 条
  • [1] Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides
    Aguilera, Todd A.
    Olson, Emilia S.
    Timmers, Margaret M.
    Jiang, Tao
    Tsien, Roger Y.
    [J]. INTEGRATIVE BIOLOGY, 2009, 1 (5-6) : 371 - 381
  • [2] Simultaneous Assessment of Luminal Integrity and Vascular Perfusion of the Gastrointestinal Tract Using Dual-Channel Near-Infrared Fluorescence
    Ashitate, Yoshitomo
    Vooght, Carrie S.
    Hutteman, Merlijn
    Oketokoun, Rafiou
    Choi, Hak Soo
    Frangioni, John V.
    [J]. MOLECULAR IMAGING, 2012, 11 (04) : 301 - 308
  • [3] Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors
    Atkins, Jordan
    Al Mushawah, Fatema
    Appleton, Catherine M.
    Cyr, Amy E.
    Gillanders, William E.
    Aft, Rebecca L.
    Eberlein, Timothy J.
    Gao, Feng
    Margenthaler, Julie A.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2012, 177 (01) : 109 - 115
  • [4] Survival and functional status after resection of recurrent glioblastoma multiforme
    Barker, FG
    Chang, SM
    Gutin, PH
    Malec, MK
    McDermott, MW
    Prados, MD
    Wilson, CB
    [J]. NEUROSURGERY, 1998, 42 (04) : 709 - 720
  • [5] Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes
    Blum, Galia
    von Degenfeld, Georges
    Merchant, Milton J.
    Blau, Helen M.
    Bogyo, Matthew
    [J]. NATURE CHEMICAL BIOLOGY, 2007, 3 (10) : 668 - 677
  • [6] Tumor-Specific Fluorescent Antibody Imaging Enables Accurate Staging Laparoscopy in an Orthotopic Model of Pancreatic Cancer
    Cao, Hop S. Tran
    Kaushal, Sharmeela
    Metildi, Cristina A.
    Menen, Rhiana S.
    Lee, Claudia
    Snyder, Cynthia S.
    Messer, Karen
    Pu, Minya
    Luiken, George A.
    Talamini, Mark A.
    Hoffman, Robert M.
    Bouvet, Michael
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (118) : 1994 - 1999
  • [7] Impact of surgical margin status on prostate-cancer-specific mortality
    Chalfin, Heather J.
    Dinizo, Michael
    Trock, Bruce J.
    Feng, Zhaoyong
    Partin, Alan W.
    Walsh, Patrick C.
    Humphreys, Elizabeth
    Han, Misop
    [J]. BJU INTERNATIONAL, 2012, 110 (11) : 1684 - 1689
  • [8] Intraoperative Fluorescence Imaging of Peripheral and Central Nerves Through a Myelin-Selective Contrast Agent
    Cotero, Victoria E.
    Siclovan, Tiberiu
    Zhang, Rong
    Carter, Randall L.
    Bajaj, Anshika
    LaPlante, Nicole E.
    Kim, Evgenia
    Gray, Daniel
    Staudinger, V. Paul
    Yazdanfar, Siavash
    Hehir, Cristina A. Tan
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (06) : 708 - 717
  • [9] Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue
    Cutter, Jennifer L.
    Cohen, Nathan T.
    Wang, Jing
    Sloan, Andrew E.
    Cohen, Alan R.
    Panneerselvam, Ashok
    Schluchter, Mark
    Blum, Galia
    Bogyo, Matthew
    Basilion, James P.
    [J]. PLOS ONE, 2012, 7 (03):
  • [10] Dotan Z. A, 2012, PROSTATE CANCER P D, V16, P73